DFTX
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$35.28
+7.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 53.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.16x
- Price / sales
- —
- Price / cash flow
- -28.41x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- —
- EV / EBITDA
- -10.87x
- EV / EBIT
- -16.23x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026